Medtronic Announces FDA Approval of Guardian Connect Mobile CGM

General News

March 14, 2018

FDA Approval

Medtronic recently announced FDA approval of its Guardian Connect mobile Continuous Glucose Monitor (CGM), along with the paired Guardian Connect App for Apple iOS devices. A limited US launch is expected between May-July 2018, with wider availability in August-October.

Guardian Connect is Medtronic’s “standalone,” real-time, mobile CGM in the US, meaning it does not send data to a paired pump – real-time CGM information goes straight to a smartphone app, similar to Dexcom’s G5.

Read more here!

Related Posts

14 March 2018

General News

14 March 2018

General News

top